Literature DB >> 20309660

N-acetylcysteine protects striated muscle in a model of compartment syndrome.

Stephen R Kearns1, David E O'Briain, Katherine M Sheehan, Cathal Kelly, David Bouchier-Hayes.   

Abstract

BACKGROUND: To avoid ischemic necrosis, compartment syndrome is a surgical emergency treated with decompression once identified. A potentially lethal, oxidant-driven reperfusion injury occurs after decompression. N-acetylcysteine is an antioxidant with the potential to attenuate the reperfusion injury. QUESTIONS/PURPOSES: We asked whether N-acetylcysteine could preserve striated muscle contractility and modify neutrophil infiltration and activation after simulated compartment syndrome release.
MATERIALS AND METHODS: Fifty-seven rats were randomized to control, simulated compartment syndrome, and simulated compartment syndrome plus N-acetylcysteine groups. We isolated the rodent cremaster muscle on its neurovascular pedicle and placed it in a pressure chamber. Chamber pressure was elevated above critical closing pressure for 3 hours to simulate compartment syndrome. Experiments were concluded at three times: 1 hour, 24 hours, and 7 days after decompression of compartment syndrome. We assessed twitch and tetanic contractile function and tissue myeloperoxidase activity. Ten additional rats were randomized to control and N-acetylcysteine administration after which neutrophil respiratory burst activity was assessed.
RESULTS: The simulated compartment syndrome decreased muscle contractility and increased muscle tissue myeloperoxidase activity compared with controls. Treatment with N-acetylcysteine preserved twitch and tetanic contractility. N-acetylcysteine did not alter neutrophil infiltration (myeloperoxidase activity) acutely but did reduce infiltration at 24 hours, even when given after decompression. N-acetylcysteine reduced neutrophil respiratory burst activity.
CONCLUSION: N-acetylcysteine administration before or after simulated compartment syndrome preserved striated muscle contractility, apparently by attenuating neutrophil activation and the resultant oxidant injury. CLINICAL RELEVANCE: Our data suggest a potential role for N-acetylcysteine in the attenuation of muscle injury after release of compartment syndrome and possibly in the prophylaxis of compartment syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309660      PMCID: PMC2895823          DOI: 10.1007/s11999-010-1287-7

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  59 in total

1.  Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation.

Authors:  D Rocksén; B Lilliehöök; R Larsson; T Johansson; A Bucht
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients.

Authors:  A R Heller; G Groth; S C Heller; R Breitkreutz; T Nebe; M Quintel; T Koch
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

3.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

Review 4.  The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review.

Authors:  F William Blaisdell
Journal:  Cardiovasc Surg       Date:  2002-12

5.  Taurine protects against early and late skeletal muscle dysfunction secondary to ischaemia reperfusion injury.

Authors:  R McLaughlin; D Bowler; C J Kelly; E Kay; D Bouchier-Hayes
Journal:  Eur J Surg       Date:  2000-05

6.  Acute compartment syndrome. Who is at risk?

Authors:  M M McQueen; P Gaston; C M Court-Brown
Journal:  J Bone Joint Surg Br       Date:  2000-03

7.  Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle.

Authors:  S R Kearns; D Moneley; P Murray; C Kelly; A F Daly
Journal:  J Bone Joint Surg Br       Date:  2001-11

8.  N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans.

Authors:  Michael J McKenna; Ivan Medved; Craig A Goodman; Malcolm J Brown; Andrew R Bjorksten; Kate T Murphy; Aaron C Petersen; Simon Sostaric; Xiaofei Gong
Journal:  J Physiol       Date:  2006-07-13       Impact factor: 5.182

9.  Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome.

Authors:  S R Kearns; A F Daly; K Sheehan; P Murray; C Kelly; D Bouchier-Hayes
Journal:  J Bone Joint Surg Br       Date:  2004-08

10.  Attenuation of ischemia/reperfusion injury by N-acetylcysteine in a rat hind limb model.

Authors:  Cengiz Koksal; A Kursat Bozkurt; Ugur Cangel; Nil Ustundag; Dildar Konukoglu; Benan Musellim; Ayla Gurel Sayin
Journal:  J Surg Res       Date:  2003-05-15       Impact factor: 2.192

View more
  4 in total

1.  Hand Compartment Syndrome Due to N-acetylcysteine Extravasation.

Authors:  Joby Thoppil; Adam Berman; Benjamin Kessler; Payal Sud; Joshua Nogar
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-18

2.  Histological analysis of the intestinal wall of newborn rats submitted to hypoxia and reoxygenation to evaluate the protective effect of N-Acetylcysteine.

Authors:  Soraia Guerra Silvares; Antonio Fernandes Moron; Manuel de Jesus Simões; Álvaro Ulhoa Cintra; Edna Frasson de Souza Montero; Edward Araujo Júnior; José Luiz Martins
Journal:  Acta Cir Bras       Date:  2020-06-05       Impact factor: 1.388

Review 3.  Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.

Authors:  Asimina Dominari; Donald Hathaway Iii; Abdulhusein Kapasi; Trissa Paul; Sarabjot Singh Makkar; Valeria Castaneda; Sirisha Gara; Bishnu Mohan Singh; Kuchalambal Agadi; Maliha Butt; Varadha Retnakumar; Spandana Chittajallu; Rahima Taugir; Muhammad Khawar Sana; Manish Kc; Sarah Razzack; Niala Moallem; Alina Alvarez; Michael Talalaev
Journal:  World J Virol       Date:  2021-03-25

4.  A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.

Authors:  Abbas Taher; Marjan Lashgari; Ladan Sedighi; Farshid Rahimi-Bashar; Jalal Poorolajal; Maryam Mehrpooya
Journal:  Pharmacol Rep       Date:  2021-06-10       Impact factor: 3.024

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.